No full text
Article (Scientific journals)
Pharma-clinics. Le medicament du mois. Le celecoxib (Celebrex).
Scheen, André
2001In Revue Médicale de Liège, 56 (1), p. 53-5
Peer reviewed
 

Files


Full Text
No document available.

Send to



Details



Keywords :
Anti-Inflammatory Agents, Non-Steroidal/pharmacology/therapeutic use; Arthritis, Rheumatoid/drug therapy; Cyclooxygenase Inhibitors/pharmacology/therapeutic use; Humans; Osteoarthritis/drug therapy; Patient Selection; Pyrazoles; Sulfonamides/pharmacology/therapeutic use; Treatment Outcome
Abstract :
[en] Celecoxib (Celebrex, Pharmacia) is a potent and selective inhibitor of the COX-2 isoform of cyclooxygenase which is used as nonsteroidal anti-inflammatory drug (NSAID). Its current indications are osteoarthritis and rheumatoid arthritis. The usual recommended daily dosage of celecoxib is 200 mg (in one or two intakes per day), to be increased up to 400 mg (two intakes per day) if necessary. Its clinical efficacy seems to be similar to that of other NSAIDs. However, its safety profile, especially gastro-intestinal tolerance and perhaps renal safety, is much better because of the COX-2 selectivity.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Language :
French
Title :
Pharma-clinics. Le medicament du mois. Le celecoxib (Celebrex).
Alternative titles :
[fr] Pharma-clinics. The drug of the month. Celecoxib (Celebrex)
Publication date :
2001
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Hopital de Baviere, Liège, Belgium
Volume :
56
Issue :
1
Pages :
53-5
Peer reviewed :
Peer reviewed
Available on ORBi :
since 06 May 2009

Statistics


Number of views
127 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
4
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi